{
  "id": "6206b399c9dfcb9c09000039",
  "type": "factoid",
  "question": "What pathological phenotype could potentially concomitant pomegranate juice and rosuvastatin use cause?",
  "ideal_answer": "Concomitant use of rosuvastatin and pomegranate juice has been hypothesized to be associated with the development of rhabdomyolysis in a case report.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/16923466"
  ],
  "snippets": [
    {
      "text": "In conclusion, because both grapefruit and pomegranate juice are known to inhibit intestinal cytochrome P450 3A4, this report suggests that pomegranate juice may increase the risk of rhabdomyolysis during rosuvastatin treatment, despite the fact that rosuvastatin is not known to be metabolized by hepatic P450 3A4.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16923466",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Rhabdomyolysis"
}